Feb 09, 1:06 p.m.
Create my watchlists and portfolios login | register
zoom
United States | Healthcare | Biotechnology
NASDAQ: NBIX.NAS at 02/09, 12:51p.m. ET - show other symbols

Neurocrine Biosciences

$ 2.40 +0.040 (+1.69%)

advertisement

Neurocrine Biosciences "neutral," target price raised

09/04/08 - UBS

NEW YORK, September 4 (newratings.com) - Analysts at UBS reiterate their "neutral" rating on Neurocrine Biosciences Inc (NBIX). The target price has been raised from $5.50 to $6.

                                                                                                                        

Make newratings better! What can newratings do better?